Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

general

One of a group of aggressive (fast-growing) non-Hodgkin lymphomas that begins in mature T lymphocytes (T cells that have matured in the thymus gland and goes to other lymphatic sites in the body, including lymph nodes, bone marrow, and spleen.)

60

Centers

118

Active Trials

$5.8B

Cancer Funding

Specific Cancer Types(5)

Top Centers for Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma(60)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
73.2
2
NCI Comprehensive
Active Research Program
67.8
3
NCI Comprehensive
Active Research Program
67.8
4
NCI Comprehensive
Active Research Program
67.8
567.8
6
NCI Comprehensive
Active Research Program
67.8
7
NCI Comprehensive
Active Research Program
67.8
8
NCI Comprehensive
Active Research Program
67.8
9
Active Research Program
67.8
10
BC CancerVancouver, BC
Active Research Program
67.8
11
NCI Comprehensive
45.8
12
NCI Comprehensive
45.8
1345.8
14
NCI Comprehensive
45.8
15
NCI Comprehensive
45.8
16
NCI Comprehensive
45.8
17
NCI Comprehensive
45.8
1845.8
1945.8
20
NCI Comprehensive
45.8
21
NCI Comprehensive
45.8
22
NCI Comprehensive
45.8
23
NCI Comprehensive
45.8
2445.8
25
NCI Comprehensive
45.8
2645.8
27
Cedars-Sinai CancerLos Angeles, CA
45.8
28
NCI Clinical
45.8
2945.8
30
NCI Comprehensive
45.8
31
NCI Comprehensive
45.8
3245.8
3345.8
3445.8
3545.8
3645.8
3745.8
3845.8
3945.8
4045.8
4145.8
4245.8
43
44
NCI Comprehensive
45
NCI Comprehensive
46
47
48
NCI Comprehensive
49
50
51
NCI Comprehensive
52
NCI Comprehensive
53
NCI Comprehensive
54
55
56
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
57
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
58
NCI Comprehensive
59
60

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →